The Lone Star State's two biggest university systems are joining hands with the world-renowned M.D. Anderson Cancer Center to help design and staff a sprawling new cancer R&D complex.
Texas A&M and the University of Texas, intense rivals on the football field, will be working together to help build the National Center for Therapeutic Manufacturing, which is under construction at the A&M campus in College Station. The new, 153,000-square-foot center is intended to help speed development of new oncology therapeutics.
"M.D. Anderson and the NCTM are and will be the standard-setters in their research areas," said A&M Chancellor Michael McKinney, M.D. "Combining the capabilities of these two institutions will radically advance the search for a cancer solution in this generation."
The new center, which should open at the end of next year, is the jewel in the crown of the Texas Emerging Technology Fund, a state-backed effort aimed at spurring new cancer research. The Legislature allocated $200 million for the fund.